发明名称 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing TNF-alpha levels
摘要 Substituted 2-(2,6-dioxopiperidin-3-yl)phtalimides and l-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF alpha in a mammal. Typical embodiments are 1-oxo-2(2,6-dioxo-3-methylpiperidin-3-yl)-4,5,6,7-tetrafluoroisoindoline and 1,3-dioxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4-aminoisoindoline.
申请公布号 AU715779(B2) 申请公布日期 2000.02.10
申请号 AU19970038998 申请日期 1997.07.24
申请人 CELGENE CORPORATION 发明人 GEORGE W. MULLER;DAVID I. STIRLING;ROGER SHEN-CHU CHEN
分类号 A61K31/4439;A61K31/445;A61K31/454;A61P1/00;A61P1/04;A61P7/00;A61P9/02;A61P9/04;A61P9/10;A61P17/06;A61P19/00;A61P19/02;A61P29/00;A61P31/06;A61P33/06;A61P35/00;A61P37/02;A61P37/06;A61P43/00;C07D401/04;(IPC1-7):C07D401/04 主分类号 A61K31/4439
代理机构 代理人
主权项
地址